Name | Value |
---|---|
Revenues | 1,817.0K |
Cost of Revenue | 1,429.0K |
Gross Profit | 388.0K |
Operating Expense | 4,421.0K |
Operating I/L | -4,033.0K |
Other Income/Expense | -443.0K |
Interest Income | 455.0K |
Pretax | -4,476.0K |
Income Tax Expense | 2,040.0K |
Net Income/Loss | -2,040.0K |
Avinger, Inc. is a medical device company specializing in image-guided and catheter-based systems for treating peripheral arterial disease (PAD). Its lumivascular platform integrates optical coherence tomography with interventional catheters, providing real-time intravascular imaging during PAD procedures. The company's products include Lightbox imaging consoles, Ocelot catheters for penetrating arterial blockages, Pantheris atherectomy device for plaque removal, and CTO-crossing catheters Wildcat and Kittycat 2. Avinger also develops IMAGE-BTK for below-the-knee PAD lesions. Its customers are interventional cardiologists, vascular surgeons, and interventional radiologists.